Downregulation of mu-opioid binding sites following chronic administration of neuropeptide FF (NPFF) and morphine

Peptides

Volumn 17, Issue 3, 1996, Pages 389-397

  Goodman, Carl B ^a   Emilien, Betsey ^a   Becketts, Karen ^a   Cadet, Jean L ^a   Rothman, Richard B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Morphine; NPFF; Opiate; Opioid receptor; Receptor autoradiography; 125I DAMGO

Indexed keywords

ENKEPHALIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE SULFATE; MU OPIATE RECEPTOR; NEUROPEPTIDE FF;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; THALAMUS NUCLEUS;

ANIMALIA;

EID: 0029953168     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(96)00002-2     Document Type: Article

References (54)

1. Allard, M.; Zajac, J.-M.; Simonnet, G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine modulating peptide, in rat central nervous system. Neuroscience 49:101-116; 1992.
2. Allard, M.; Theodosis, D. T.; Rousselot, P.; Lombard, M. C.; Simonnet, G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: Biochemical and immunocytochemical studies. Neuroscience 40:81-92; 1991.
3. Bhargava, H. N.; Gulati, A. Down-regulation of brain and spinal cord μ-opiate receptors in morphine tolerant-dependent rats. Eur. J. Pharmacol. 190:305-311; 1990.
4. Brady, L. S.; Herkenham, M.; Long, J. B.; Rothman, R. B. Chronic morphine increases μ-opiate receptor binding in rat brain: a quantitative autoradiographic study. Brain Res. 477:382-386; 1989.
5. Brussaard, A. B.; Kits, K. S.; Maat, A. T.; Mulder, A. H.; Schoffelmeer, A. N. H. Peripheral injection of DNS-RFa, a FMRFa agonist, suppresses morphine-induced analgesia in rats. Peptides 10:735-739; 1989.
6. Creese, I.; Sibley, D. R. Receptor adaptations to centrally administered drugs. Annu. Rev. Pharmacol. Toxicol. 21:357-391; 1981.
7. 5]enkephalin binding sites by different mechanisms. Neuropharmacology 27:965-974; 1988.
8. Danks, J. A.; Tortella, F. C.; Bykov, V.; Jacobson, A. E.; Rice, K. C.; Rothman, R. B. Up-regulation of the mu-non-competitive delta binding site by chronic morphine administration: Effect of preincubating membranes in 400 mM sodium chloride. NIDA Res. Monogr. 75:93-96; 1986.
9. Dockray, G. L.; Vaillant, C.; Williams, R. G. New vertebrate brain -gut peptide related to a molluscan neuropeptide and an opioid peptide. Nature 293:665-666; 1981.
10. Goodman, C. B.; Emilien, B.; Cadet, J. L.; Yang, H. -Y. T.; Lee, C.-H.; Rothman, R. B. Chronic ICV infusion with monoclonal anti-NPFF IgG up-regulates mu opioid binding sites in rat brain: An autoradiographic study. Biol. Psychiatry 35:401; 1994.
11. Goodman, C. B.; Elmer, G. I.; Yang, H.-Y. T.; Lee, C.-H.; Rothman, R. B. Modulation of opioid receptors by anti-opioid peptides. In: Tseng, L. F., ed. Pharmacology of opioid peptides. Singapore: Harwood Academic Publishers, gmbh; 1995.
12. Gouarderes, C.; Jhamandas, K.; Zajac, J. M.; Beaudet, A.; Cros, J.; Quirion, R. Modulation of mu opioid binding sites in rat spinal cord by chronic intrathecal infusion of morphine and naloxone: A quantitative autoradiography approach. Prog. Clin. Biol. Res. 328:175-178; 1990.
13. Hammer, R. P., Jr.; Seatriz, J. V.; Ricalde, A. R. Regional dependence of morphine-induced μ-opiate receptor downregulation in perinatal rat brain. Eur. J. Pharmacol. 209:253-256; 1991.
14. Herkenham, M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 23:1-38; 1987.
15. Herz, A.; Teschemacher, H. J. Activities and sites of antinociceptive action of morphine-like analgesics and kinetics of distribution following intravenous, intracerebral and intraventricular application. Adv. Drug Res. 6:79-119; 1971.
16. 3H-naloxone in the mouse brain: Effect of ions and tolerance development. Life Sci. 14:2393-2404; 1974.
17. 5-enkephalin binding sites in rat brain. Life Sci. 31:2359-2362; 1982.
18. Huffman, R. D.; Simmons, K. E.; Lum, J. T. An intraventricular infusion model for inducing morphine dependence in rats: Quantitative assessment of precipitated withdrawal. Behav. Neurosci. 99:861-880; 1985.
19. Kavaliers, M.; Yang, H. -Y. T. IgG from antiserum against endogenous mammalian FRMF-NH2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides 10:741-745; 1989.
20. Kivipelto, L.; Panula, P. Central neural pathways containing FLFQPQRF amide-like (morphine-modulating) peptides in the rat brain. Neuroscience 41:137-148; 1991.
21. Klee, W. A.; Streaty, R. A. Narcotic receptor sites in morphine-dependent rats. Nature 248:61-64; 1974.
22. Knott, G. D.; Reece, D. K. MLAB: A civilized curve fitting system. Proc. Online 1972 Int. Conf. 1:497-526; 1972.
23. Law, P. Y.; Hom, D. S.; Loh, H.H. Opiate receptor downregulation and desensitization in neuroblastoma X glioma NG1089-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24:413-424; 1983.
24. Lowry, O. H.; Rosebrough, N. H.; Farr, A. L.; Randall, P. J. Protein measurement with folin phenol reagent. J. Biol. Chem. 193:265-275; 1951.
25. 2 with μ and δ opioid antinociception in the rat spinal cord. Neuropeptides 16:213-218; 1990.
26. Makimurea, M.; Horan, P. J.; Hoskins, B.; Ho, I. K. Alterations in opioid receptor binding following continuous ICV administration of butorphanol and morphine. Soc. Neurosci. Abstr. 16:159.6; 1990.
27. 2-like mammalian octapeptide precipitates opiate-withdrawal syndrome in the rat. Peptides 11:277-280; 1990.
28. Mansour, A.; Khachaturian, H.; Lewis, M. E.; Akil, H.; Watson, S. J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:2445-2464; 1987.
29. McGonigle, P.; Neve, K. A.; Molinoff, P. B. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes. MoL. Pharmacol. 30:329-337; 1986.
30. McLean, S.; Rothman, R. B.; Herkenham, M. Autoradiographic Localization of μ- and δ-opiate receptors in the forebrain of the rat. Brain Res. 378:49-60; 1986.
31. Munson, P. J.; Rodbard, D. LIGAND: A versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:220-239; 1980.
32. Panula, P.; Kivipelto, L.; Nieminen, O.; Majane, E. A.; Yang, H. Y. T. Neuroanatomy of morphine modulating peptides. Med. Biol. 65:127-135; 1987.
33. Payza, K.; Yang, H. Y. Modulation of neuropeptide FF receptors by guanine nucleotides and cations in membranes of rat brain and spinal cords. J. Neurochem. 60:1894-1899; 1993.
34. 2b receptors. Peptides 15:401-404; 1994.
35. Rogers, N. F.; El-Fakahany, E. E. Morphine-induced opioid receptor downregulation detected in intact adult rat brain cells. Eur. J. Pharmacol. 124:221-230; 1986.
36. Rothman, R. B. Analysis of binding surfaces: a methodology appropriate for the investigation of complex receptor mechanisms and multiple neurotransmitter receptors. Neuropeptides 4:41-44; 1983.
37. Rothman, R. B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse 12:129-138; 1992.
38. Rothman, R. B. Binding surface analysis: An intuitive yet quantitative method for the design and analysis of ligand binding studies. Alcohol Drug Res. 6:309-325; 1986.
39. 5]enkephalin: Further evidence for two μ-binding sites. Eur. J. Pharmacol. 160:71-82; 1989.
40. 2 (NPFF), downregulates mu opioid binding sites in rat brain. Peptides 14:1271-1277; 1993.
41. Rothman, R. B.; Danks, J. A.; Jacobson, A. E.; et al. Morphine tolerance increases μ-noncompetitive delta binding sites. Eur. J. Pharmacol. 124:113-119; 1986.
42. Rothman, R. B.; Yang, H. -Y. T.; Long, J. B. Upregulation of rat brain opioid receptors by the chronic administration of morphine: Possible evidence for an anti-opiate model of tolerance and dependence. NIDA Res. Monogr. 105:264-270; 1991.
43. Rothman, R. B.; Long, J. B.; Bykov, V.; et al. Upregulation of the opioid receptor complex by the chronic administration of morphine: A biochemical marker related to the development of tolerance and dependence. Peptides 12:151-160; 1991.
44. max in ligand binding experiments. II Simultaneous analysis of homologous and heterologous competition curves and analysis blocking and of "multiligand" dose-response surfaces. Anal. Biochem. 184:172-183; 1990.
45. 2-like immunoreactivity. Proc. Natl. Acad. Sci. USA 81:5002-5005; 1984.
46. Tempel, A.; Gardner, E. L.; Zukin, S. Neurochemical and functional correlates of naltrexone-induced opiate receptor upregulation. J. Pharmacol. Exp. Ther. 232:439-444; 1985.
47. Tempel, A.; Gardner, E. L.; Zukin, R. S. Visualization of opiate receptor up-regualtion by light microscope autoradiography. Proc. Natl. Acad. Sci. USA 81:3893-3897; 1984.
48. Yang, H. -Y. T.; Fratta, W.; Majane, E. A.; Costa, E. Isolation, sequencing, synthesis and pharmacological characterization of two neuropeptides that modulate the actions of morphine. Proc. Natl. Acad. Sci. USA 82:7757-7761; 1985.
49. Yoburn, B. C.; Goodman, R. R.; Cohen, A. H.; Pasternak, G. W.; Inturrisi, C. E. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment. Life Sci. 36:2325-2332; 1985.
50. Yoburn, B. C.; Billings, B.; Duttaroy, A. Opioid receptor regulation in mice. J. Pharmacol. Exp. Ther. 265:314-320; 1993.
51. Yoburn, B. C.; Sierra, V.; Lutfy, K. Simultaneous development of opioid tolerance and opioid antagonist-induced receptor upregulation. Brain Res. 529:143-148; 1990.
52. Zadina, J. E.; Harrison, L. M.; Ge, L.-J.; Kastin, A. J.; Ghang, S. L. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 270: 10986-96; 1994.
53. Zadina, J. E.; Chang, S. L.; Ge, L.-J.; Kastin, A. J. Mu opiate receptor downregulation by morphine and upregulation by naloxone in SH-SY5Y human neuroblastoma cells. J. Pharmacol. Exp. Ther. 265: 254-262; 1993.
54. Zukin, R. S.; Sugarman, J. R.; Fitz-Syage, M. L.; Gardner, E. L.; Zukin, S. R.; Gintzler, A. R. Naltrexone-induced opiate receptor supersensitivity. Brain Res. 245:285-292; 1982.